Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: Results of Radiation Therapy Oncology Group phase II trial 8802

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 119-126

  Tester, W ^a   Caplan, R ^a   Heaney, J ^a   Venner, P ^a   Whittington, R ^a   Byhardt, R ^a   True, L ^a   Shipley, W ^a  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CYSTECTOMY; CYSTITIS; DIARRHEA; DOSE RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURGICAL APPROACH; THROMBOCYTOPENIA; TREATMENT FAILURE;

EID: 0030030350     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.119     Document Type: Article

References (41)

1. Moore MJ, O'Sullivan B, Tannock IF: How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 6:1736-1745, 1988
2. Thrasher JB, Crawford ED: Current management of invasive and metastatic transitional cell carcinoma of the bladder. J Urol 149:957-972, 1993
3. Gospodarowicz MK, Rider WD, Keen CW, et al: Bladder cancer: Long-term follow-up results of patients treated with radical radiation. Clin Oncol 3:155-161, 1991
4. Salminen E: External beam radiation treatment of urinary bladder carcinoma. An analysis of results in 203 patients. Acta Oncol 29:909-914, 1990
5. Shipley WU, Rose MA: The selection of patients for treatment by full-dose irradiation. Cancer 55:2278-2284, 1985
6. Shipley WU, Prout GR, Einstein AB, et al: Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258:931-935, 1987
7. Mothersill C, Seymour CB, Cusack A, et al: The effect of radiation and cytotoxic platinum compounds on the growth of normal and tumour bladder explant cultures. Acta Oncol 29:179-184, 1990
8. Soloway MS, Morris CR, Sudderth B: Radiation therapy and cisdiammine-dichloroplatinum (II) in transplantable and primary murine bladder cancer. Int J Radiat Oncol Biol Phys 5:1355-1360, 1979
9. Dunst J, Sauer R, Schrott KM, et al: Organ-sparing treatment of advanced bladder cancer: A 10-year experience. Int J Radiat Oncol Biol Phys 30:261-266, 1994
10. Tester W, Porter A, Asbell S, et al: Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 25:783-790, 1993
11. Meyers FJ, Palmer JM, Freiha FS, et al: The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate, and vinblastine. J Urol 134:1118-1121, 1985
12. Vogelzang NJ, Moormeier JA, Awan AM, et al: Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: The University of Chicago experience. J Urol 149:753-757, 1993
13. Loehrer PJ, Einhorn LH, Elson PJ, et al: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study. J Clin Oncol 10:1066-1073, 1992
14. Kaufman DS, Shipley WU, Griffin PP, et al: Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 329:1377-1382, 1993
15. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346, 1995
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
17. Gaynor JJ, Feuer EJ, Tan CC, et al: On the use of cause-specific failure and conditional failure probabilities. J Am Stat Assoc 88:400-409, 1993
18. Agresti A: Analysis of Ordinal Categorical Data. New York, NY, Wiley, 1984
19. Cox DR: Regression methods and life tables (with discussion). J R Stat Soc 34:187-220, 1972
20. Cervek J, Cufer T, Kragelj B, et al: Sequential transurethral surgery, multiple drug chemotherapy and radiation therapy for invasive bladder carcinoma: Initial report. Int J Radiat Oncol Biol Phys 25:777-782, 1993
21. Housset M, Maulard C, Chretien Y, et al: Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study. J Clin Oncol 11:2150-2157, 1993
22. Rebischung JL, Vannetzel JM, Fournier F, et al: Cyclic concomitant chemoradiotherapy for invasive bladder cancer: Phase II study with organ preservation. Proc Am Soc Clin Oncol 11:208, 1992 (abstr)
23. Rifkin MN, Oblon D, Parsons J, et al: Bladder-sparing treatment for muscle invasive bladder cancer with systemic chemotherapy followed by radiation therapy and adjuvant cisplatin: A 3-yr follow-up (meeting abstract). Proc Am Soc Clin Oncol 11:198, 1992 (abstr)
24. Russell KJ, Boileau MA, Higano C, et al: Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 99:693-699, 1990
25. Rubinov R, Sapir D, Steiner M: Combined chemoradiotherapy in the treatment of invasive bladder cancer. Ann Oncol 3:109, 1992 (suppl 5; abstr)
26. Canobbio L, Decensi A, Guarneri D, et al: Transurethral surgery, alternating chemotherapy and radiation with bladder sparing in invasive bladder cancer patients. Proc Am Soc Clin Oncol 11:220, 1992 (abstr)
27. Curotto A, Boccardo F, Canobbio L, et al: Chemoradiotherapy in locally advanced bladder cancer: Neoadjuvant and definitive treatment, in Salmon SE (ed): Adjuvant Therapy of Cancer, vol 7. Philadelphia, PA, Lippincott, 1993, pp 320-328
28. Rotman M, Aziz H, Porrazzo M, et al: Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion. Int J Radiat Oncol Biol Phys 18:1131-1137, 1990
29. Coppin C, Gospodarowicz M, Dixon P, et al: Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or radical radiation. Proc Am Soc Clin Oncol 11:198, 1992 (abstr)
30. Veenema RJ, Harisiadis L, Chang C, et al: Bladder carcinoma: Preliminary external radiotherapy used as a means for selecting complete treatment, in Connolly JG (ed): Carcinoma of the Bladder. New York, NY, Raven, 1981, pp 182-191
31. Crawford ED, Skinner DG: Salvage cystectomy after irradiation failure. J Urol 123:32-34, 1980
32. Jenkins BJ, Caulfield MJ, Fowler CG, et al: Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br J Urol 62:343-346, 1988
33. Sell A, Jakobsen A, Nerstrm B, et al: Treatment of advanced bladder cancer category T2, T3, and T4A. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. Scand J Urol Neprol [Suppl] 138:893-901, 1991
34. Abratt RP, Pontin AR, Barnes RD: Chemotherapy, radical irradiation plus salvage cystectomy for bladder cancer - Severe late small bowel morbidity. Eur J Surg Oncol 99:279-282, 1993
35. Martinez-Piniero JA, Martin MG, Arocenta F, et al: Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: A prospective randomized phase III study. J Urol 153:964-973, 1995
36. Rintala E, Hannisdahl E, Fossa SD, et al: Neo-adjuvant chemotherapy in bladder cancer: A randomized study. Nordic Cystectomy Trial 1. Scand J Urol Nephrol 27:355-362, 1993
37. Roth BJ, Dreicer R, Einhorn LH, et al: Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: A phase II trial of the Eastern Cooperative Oncology Group. J Clin Oncol 12:2264-2270, 1994
38. Witte R, Loehrer P, Dreicer R, et al: Ifosfamide in advanced urothelial carcinoma: An ECOG trial. Proc Am Soc Clin Oncol 12:230, 1993 (abstr)
39. Seligman PA, Crawford ED: Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate. J Natl Cancer Inst 83:1582-1584, 1991
40. Pollera CF, Ceribelli A, Crecco M, et al: Weekly gemcitabine in advanced bladder cancer: A preliminary report from a phase I study. Ann Oncol 5:182-184, 1994
41. Raghavan D: Keynote Address: A critical assessment of trials of neoadjuvant (preemptive) chemotherapy for bladder cancer: Lesson for future studies of combined modality treatment. Int J Radiat Oncol Biol Phys 20:233-237, 1991